Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2026-07-18 @ 11:27 PM
Study NCT ID:
NCT01497366
Status:
COMPLETED
Last Update Posted:
2014-04-02
First Post:
2011-12-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Sofosbuvir and Ribavirin
Sponsor:
Gilead Sciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P7977-1231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None